Bioabsorbable Stents Market Report 2025

This Bioabsorbable Stents market report provides a comprehensive analysis of the market’s characteristics, size, and growth, including segmentation, regional and country-level breakdowns, competitive landscape, market shares, trends, and strategies. It also tracks historical and forecasted market growth across various geographies.

The bioabsorbable stents market size has grown strongly in recent years. It will grow from $0.37 billion in 2024 to $0.41 billion in 2025 at a compound annual growth rate (CAGR) of 9.9%. The growth in the historic period can be attributed to rising prevalence of cardiovascular diseases, growing demand for minimally invasive procedures, increasing awareness of bioabsorbable stents, rising disposable incomes, industry investments.

The bioabsorbable stents market size is expected to see strong growth in the next few years. It will grow to $0.59 billion in 2029 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to expanded clinical indications, customization and personalization, global expansion, patient-friendly option. Major trends in the forecast period include advancements in bioabsorbable materials, clinical advancements, clinical data and research, hybrid stent designs, longer absorption periods, collaborations and partnerships.

The rising incidence of cardiovascular diseases is a pivotal factor contributing to the growth of the bioabsorbable stents market. Cardiovascular conditions stand as the foremost cause of global mortality, with four out of five cardiovascular-related deaths resulting from strokes and heart attacks. Disturbingly, a third of these fatalities occur prematurely in individuals under 70. To counter late complications linked with conventional metal stents, bioresorbable stents aim to address concerns such as scaffold thrombosis or restenosis by dissolving gradually in the body. Projections from the American Heart Association suggest an estimated toll of over 23.6 million deaths attributable to cardiovascular diseases by 2030. Thus, the surge in cardiovascular conditions is anticipated to steer the bioabsorbable stents sector.

The rising incidence of heart failure is poised to act as a catalyst for the bioabsorbable stents market's growth. Heart failure, characterized by the heart's weakened pumping capacity, leads to fluid retention in the body. Bioabsorbable stents find applications in managing heart failure by improving heart function and alleviating related symptoms. For example, in February 2022, the Heart and Stroke Foundation of Canada, a Canada-based organization providing information on stroke, heart disease, surgeries, and treatments, reported that 750,000 individuals are currently diagnosed with heart failure, with an annual increase of 100,000 new cases of this incurable condition. Projections suggest that by 2030, healthcare expenditures related to heart failure in Canada are expected to reach $2.8 billion annually. As a result, the rising prevalence of heart failure is expected to drive the growth of the bioabsorbable stents market moving forward.

Major companies operating in the bioabsorbable stents market are focusing on innovating new technologies, such as the latest generation of bioresorbable cardiac stents, to enhance their profitability and market share. These advanced medical devices, designed for treating coronary artery disease, are made from biodegradable materials that dissolve over time after performing their function of keeping the artery open. For example, in July 2024, MicroPort Scientific Corporation, a China-based medical device manufacturer, received market approval for the world’s first next-generation fully bioresorbable cardiac stent from China's National Medical Products Administration (NMPA). Developed by MicroPort, the Firesorb stent is designed to completely dissolve within three years, significantly reducing long-term complications such as thrombosis. Clinical trials involving 1,468 patients demonstrated impressive results, including a low thrombosis rate of 0.32% and a 4-year target lesion failure rate of just 4.3%. Medical experts have praised the Firesorb stent for its innovative thin strut design and superior endothelial coverage compared to previous stent generations.

The introduction of innovative technologies, such as the Orsiro Mission bioabsorbable polymer drug-eluting stent system (BP-DES), is a strategic move by major companies in the bioabsorbable stents market to enhance their market share and profitability. Biotronik, a Germany-based medical device manufacturer, unveiled the Orsiro Mission BP-DES in Canada in April 2023. This system is designed to address coronary artery disease by expanding the diameter of coronary arteries in patients dealing with conditions like diabetes mellitus and other related ailments.

Major companies operating in the bioabsorbable stents market include Abbott Laboratories, REVA Medical Inc., Elixir Medical Corporation, Biotronik SE & Co. KG, Amaranth Medical Inc., Zorion Medical Inc., Tepha Inc., S3V Vascular Technologies, ICON Interventional Systems Inc., Arterius Limited, Microport Scientific Corporation, Meril Life Sciences Pvt. Ltd., Medlogics Device Corporation, B. Braun Melsungen AG, Boston Scientific Corporation, C.R. Bard Inc., Stentys SA, Terumo Corporation, OrbusNeich, Arterial Remodeling Technologies, Cardionovum GmbH, Envision Scientific Pvt Ltd., Eurocor GmbH, Hexacath, Kyoto Medical Planning Co. Ltd., Lifetech Scientific (Shenzhen) Co. Ltd., Manli Cardiology Limited, Medtronic Inc., QualiMed Innovative Medizinprodukte GmbH, Sahajanand Medical Technologies Pvt. Ltd., Sinomed, Surmodics Inc., Translumina Therapeutics, Vascular Concepts Limited, Xenogenics Corporation.

Bioabsorbable stents are vascular tubes used for unblocking blood vessels and subsequently dissolve within the body after a certain period.

The primary products in the bioabsorbable stents market consist of polymer-based and metal-based bioabsorbable stents. These stents, also referred to as bioresorbable stents or vascular scaffolds, are designed to fully disintegrate within the body. Additionally, these stents are categorized based on their absorption rates into slow-absorption and fast-absorption stents, and they find applications in treating coronary artery diseases and peripheral artery diseases.

The bioabsorbable stents market research report is one of a series of new reports that provides bioabsorbable stents market statistics, including bioabsorbable stents industry global market size, regional shares, competitors with a bioabsorbable stents market share, detailed bioabsorbable stents market segments, market trends and opportunities, and any further data you may need to thrive in the bioabsorbable stents industry. This bioabsorbable stents market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

North America was the largest region in the bioabsorbable stents market in 2024. Western Europe was the second-largest region in the bioabsorbable stents market report. The regions covered in the bioabsorbable stents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the bioabsorbable stents market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The bioabsorbable stents market consists of sales of polymer-based bioabsorbable stents and metal-based bioabsorbable stents. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.